First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial - Related Studies

First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial (FAST)

This study has been completed.

Study NCT01232920 Information provided by University of California, San Francisco

First Received on November 1, 2010. Last Updated on March 13, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Uveitis

Additional conditions recognized in this trial

Chorioretinitis

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Antimetabolites
Mycophenolic Acid

More general drug interventions related to this trial

Sponsors listed in this trial